Wedbush has issued a report reiterating the Outperform Rating of Illumina ILMN.
Wedbush writes, "Shares likely to regain mojo over the remainder of 2011, in our opinion. Reaffirming OUTPERFORM. ILMN currently trades at a premium to the peer group on most metrics including PE (43x vs 18x), PEG (1.4x vs 1.3x), and EV/Sales (6.9x vs 2.1x). Our $75 12-18 month price target is based on a 2011E EV/Sales multiple of 8.5x and PEG of 1.7x. We believe our higher EV/sales multiple is reasonable given the company's continually fierce pace of innovation and increasing dominance in sequencing which remains in its early innings."
Illumina has a $75 PT and traded at $62.11 yesterday at closing.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in